跳至主要内容
临床试验/ACTRN12626001003369
ACTRN12626001003369进行中(未招募)不适用

HeartPath+: A single site pilot Type 1 hybrid effectiveness/implementation feasibility study to test the co-designed HeartPath+ website for patients with coronary heart disease

Monash University0 个研究点目标入组 160 人开始时间: 2026年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Educational / counselling / training
盲法
None

入排标准

年龄范围
18 Years 至 No limit(—)
性别
All

入选标准

  • Participants will be eligible for the study if ALL of the following inclusion criteria are met:
  • Aged 18 years and over
  • Able to provide informed consent in English or in preferred language of Mandarin or Russian with an interpreter present
  • Diagnosis of coronary heart disease (CHD) (angina and all forms of acute coronary syndrome)
  • Lives independently at home
  • Has access to a device which can connect to the HeartPath+ website
  • Willing to access the HeartPath+ website (if in the intervention arm) and complete study requirements

排除标准

  • Participants be ineligible for the study if ANY of the following exclusion criteria apply:
  • Unable to provide consent
  • Living in supported accommodation or aged care
  • Clinically unstable/unwell (e.g currently in ICU)
  • Terminal diagnosis
  • Participant not willing to use the HeartPath+ website or is unable to access the site

研究者

相似试验

HeartPath+: A single site... | 临床试验